Camden Capital »

Ascendis Pharma AS shares owned by Camden Capital

Quarter-by-quarter ownership of Ascendis Pharma AS (ASND) shares owned by Camden Capital from 13F filings

Historical chart of Camden Capital investment in Ascendis Pharma AS

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma AS held by Camden Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma AS by Camden Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $312k 1.2k 266.72

More positions owned by Camden Capital

Micron Technology Stock (MU)
Citigroup Stock (C)
Apple Stock (AAPL)
Vanguard S&p 500 Etf Etf (VOO)
General Electric Stock (GE)
Onemain Hldgs Stock (OMF)
Ishares Core S&p 500 Etf Etf (IVV)
Nvidia Corp Stock (NVDA)
Intel Corp Stock (INTC)
Morgan Stanley Stock (MS)
Schwab U.s. Large-cap Growth Etf Etf (SCHG)
New York Cmnty Bancorp Stock (FLG)
Bk Of America Corp Stock (BAC)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Wells Fargo Stock (WFC)

View all positions for Camden Capital

Top funds holding Ascendis Pharma AS

T. Rowe Price Associates
Principal Financial Group
Pictet Asset Management Holding SA
A.R. Schmeidler & Co
New York State Common Retirement Fund
Walleye Trading Advisors
Driehaus Capital Management
TD Asset Management
Q Global Advisors
Sapient Capital
Walleye Trading
Tudor Investment Corporation
Standard Life Aberdeen
Handelsbanken Fonder AB
Diversified Trust Company

View all funds holding Ascendis Pharma AS